MedPath

广西千珍制药有限公司

Ownership
-
Established
2001-08-31
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

33

NMPA:33

Drug Approvals

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H45020487
Approval Date
Jan 17, 2025
NMPA

罗汉果止咳糖浆

Approval Number
国药准字Z45021303
Approval Date
Jan 6, 2025
NMPA

川贝枇杷糖浆

Approval Number
国药准字Z45020801
Approval Date
Jan 6, 2025
NMPA

十滴水

Approval Number
国药准字Z45020805
Approval Date
Jan 6, 2025
NMPA

消炎利胆片

Approval Number
国药准字Z45020806
Approval Date
Jan 6, 2025
NMPA

穿心莲片

Approval Number
国药准字Z45021296
Approval Date
Jan 6, 2025
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H45020484
Approval Date
Jan 6, 2025
NMPA

Compound Paracetamol and Chlorphenamine Maleate Granules

Product Name
复方氨酚那敏颗粒
Approval Number
国药准字H45021068
Approval Date
Jan 6, 2025
NMPA

二冬膏

Approval Number
国药准字Z45021798
Approval Date
Jan 6, 2025
NMPA

止咳枇杷糖浆

Approval Number
国药准字Z45021306
Approval Date
Jan 6, 2025
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.